|
Proteintech
polyclonal anti ap3β1 Polyclonal Anti Ap3β1, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/ap3b1+hps2/10__1091_slash_mbc__e10___10___0799-280-114-117?v=Proteintech Average 93 stars, based on 1 article reviews
polyclonal anti ap3β1 - by Bioz Stars,
2026-08
93/100 stars
|
Buy from Supplier |
|
OriGene
ap 3 complex ap3b1 Ap 3 Complex Ap3b1, supplied by OriGene, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/ap3b1+hps2/10__1128_slash_jvi__00544___12-49-8-14?v=OriGene Average 90 stars, based on 1 article reviews
ap 3 complex ap3b1 - by Bioz Stars,
2026-08
90/100 stars
|
Buy from Supplier |
|
OriGene
mrna ap3b1  Mrna Ap3b1, supplied by OriGene, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/ap3b1+hps2/pmc11437497-71-7-9?v=OriGene Average 92 stars, based on 1 article reviews
mrna ap3b1 - by Bioz Stars,
2026-08
92/100 stars
|
Buy from Supplier |
|
AP3B1 rabbit polyclonal antibody
|
Buy from Supplier |
|
Transient overexpression of AP3B1 NM 003664 in HEK293T cells paraffin embedded 4 um sections controls for ICC IHC staining 5 slides per pack
|
Buy from Supplier |
|
AP3B1 untagged Human adaptor related protein complex 3 beta 1 subunit AP3B1
|
Buy from Supplier |
|
AP3B1 Human 4 unique 29mer shRNA constructs in lentiviral GFP vector
|
Buy from Supplier |
|
AP3B1 Human shRNA lentiviral particles 4 unique 29mer target specific shRNA 1 scramble control 0 5 ml each 10 7 TU ml
|
Buy from Supplier |
|
Lenti ORF clone of Human adaptor related protein complex 3 beta 1 subunit AP3B1 Myc DDK tagged
|
Buy from Supplier |
|
AP3B1 Myc DDK tagged Homo sapiens adaptor related protein complex 3 beta 1 subunit AP3B1 transcript variant 2
|
Buy from Supplier |
Image Search Results
Journal: Viruses
Article Title: AP3B1 Has Type I Interferon-Independent Antiviral Function against SARS-CoV-2
doi: 10.3390/v16091377
Figure Lengend Snippet: AP3B1 interacts with SARS-CoV-2 E. ( A ) A549 (ACE2) cells were infected with SARS-CoV-2 (MOI 1) and stained for endogenous AP3B1 (green) and SARS-CoV-2-E (red), revealing colocalization (yellow) of the two proteins. Scale bar represents 10 μM. Representative image shown from two independent experiments. White box depicts area shown in Inset. ( B ) Colocalization analysis of endogenous AP3B1 in uninfected A549 cells (green; Quadrant 2 of left panel) or cells infected with SARS-CoV-2 counterstained for the viral Envelope (E) protein (red; Quadrant 1 of right panel). Pixels where colocalization is apparent in Quadrant 3 are pseudo-colored white.
Article Snippet: The following primers were used to amplify
Techniques: Infection, Staining
Journal: Viruses
Article Title: AP3B1 Has Type I Interferon-Independent Antiviral Function against SARS-CoV-2
doi: 10.3390/v16091377
Figure Lengend Snippet: AP3B1 interacts with SARS-CoV-2 E following ectopic expression. ( A ) HEK293 cells were transfected with Flag-SARS-CoV-2-E and HA-AP3B1. Co-immunoprecipitation of Flag-SARS-CoV-2-E was observed when HA-AP3B1 was subjected to affinity purification. Representative images shown from three independent experiments. ( B ) Co-immunoprecipitation of HA-AP3B1 following affinity purification of Flag-SARS-CoV-2 E. Representative images shown from three independent experiments. WCE, whole cell extract.
Article Snippet: The following primers were used to amplify
Techniques: Expressing, Transfection, Immunoprecipitation, Affinity Purification
Journal: Viruses
Article Title: AP3B1 Has Type I Interferon-Independent Antiviral Function against SARS-CoV-2
doi: 10.3390/v16091377
Figure Lengend Snippet: AP3B1 ear domain is insufficient for inhibition of SARS-CoV-2. ( A ) A549 cells expressing human ACE2 were transfected with plasmids encoding full-length AP3B1 or the ear domain of AP3B1 only and infected with SARS-CoV-2 for 48 h. Release of infectious virus was measured by plaque assay. ( B ) Samples from ( A ) were analyzed by Western blotting for SARS-CoV-2 spike protein expression and ( C ) viability by MTT assay. Representative images shown from two independent experiments. ( D ) Immunofluorescence analysis of colocalization between full-length HA-AP3B1 (top panel) or HA-AP3B1 ear domain (bottom panel) and SARS-CoV-2 E (red). Scale bar represents 10 μM. Representative images shown from two independent experiments. White box depicts area shown in Inset. ( E ) Quantification of correlation coefficient from two independent experiments; data points represent individual cells. Error bars represent mean ± SD with statistics from one-way ANOVA with ( A ) Tukey’s post test or ( B ) Sidak’s post test. Data in ( E ) analyzed by two-way t -test. NS, not significant, *** p < 0.0005, **** p < 0.0001.
Article Snippet: The following primers were used to amplify
Techniques: Inhibition, Expressing, Transfection, Infection, Virus, Plaque Assay, Western Blot, MTT Assay, Immunofluorescence
Journal: Viruses
Article Title: AP3B1 Has Type I Interferon-Independent Antiviral Function against SARS-CoV-2
doi: 10.3390/v16091377
Figure Lengend Snippet: AP3B1 is antiviral for SARS-CoV-2, not SARS-CoV. ( A ) A549 cells expressing human ACE2 were treated with siRNA against AP3B1 or a scrambled control, and infected with SARS-CoV-2. Virus replication was monitored over time by plaque assays of infectious virus in cell supernatants. **** p < 0.0001 by one-way ANOVA with Tukey’s post test. ( B ) Samples from ( A ) were analyzed by Western blotting for SARS-CoV-2 spike protein expression and AP3B1 protein levels. Representative image shown from three independent experiments. ( C ) Immunofluorescence staining for viral dsRNA (red) in SARS-CoV-2-infected A549 cells expressing human ACE2 treated with siRNA against AP3B1 or a scrambled control. Scale bar represents 30 μM. DAPI staining of nuclei is shown in blue. ( D ) Quantification of ( C ) across four fields and analyzed by standard t -test. ( E ) A549 cells expressing human ACE2 were treated with siRNA against AP3D1 or a scrambled control, and infected with SARS-CoV-2. Virus replication was monitored over time by plaque assays of infectious virus in cell supernatants from three experiments. NS, not significant measured by one-way ANOVA. ( F ) A549 cells expressing human ACE2 were treated with siRNA against AP3B1 or a scrambled control, and infected with SARS-CoV. Virus replication was monitored over time by plaque assays of infectious virus in cell supernatants from three experiments. NS, not significant measured by one-way ANOVA. ( G ) Samples from ( F ) were analyzed by Western blotting for SARS-CoV spike protein expression. All error bars represent mean ± SD.
Article Snippet: The following primers were used to amplify
Techniques: Expressing, Control, Infection, Virus, Western Blot, Immunofluorescence, Staining
Journal: Viruses
Article Title: AP3B1 Has Type I Interferon-Independent Antiviral Function against SARS-CoV-2
doi: 10.3390/v16091377
Figure Lengend Snippet: AP3B1 is not interferon inducible. ( A ) A549 cells expressing human ACE2 were treated with 100 units/mL of IFNβ and analyzed for ISG15 and AP3B1 protein expression or ( B ) expression of AP3B1, IFITM1, and ISG15 mRNA normalized to 18s ribosomal RNA. Increased expression of ISG15 and IFITM1 confirms IFNβ stimulation of treated cells. Error bars represent mean ± SD; statistics performed by unpaired t -test; ns = not significant, ** p < 0.005, *** p < 0.0005.
Article Snippet: The following primers were used to amplify
Techniques: Expressing